---
figid: PMC8692584__fimmu-12-769167-g001
figtitle: 'E3 Ubiquitin Ligases and Deubiquitinases in Inflammatory Bowel Disease:
  Friend or Foe?'
organisms:
- Citrobacter rodentium
- bacterium A-20
- Homo sapiens
- Mus musculus
- Murine norovirus
organisms_ner:
- Mus musculus
- Homo sapiens
- Danio rerio
pmcid: PMC8692584
filename: fimmu-12-769167-g001.jpg
figlink: /pmc/articles/PMC8692584/figure/f1/
number: F1
caption: 'Activation and regulation of NF-κB pathway. (A) Canonical NF-κB activation:
  The binding of TNFRs to the ligands leads to the recruitment of TRADD, RIPK1. TRADD
  subsequently recruits E3 ubiquitin ligases, including TRAFs, cIAP1/2 and LUBAC.
  RIPK1 is then ubiquitinated and acts as a ubiquitin scaffold to recruit the IKK
  complex and the TAK1 complex. The IKK complex is comprised of IKKα, IKKβ, and NEMO.
  The TAK1 complex consists of TABs and TAK1.TAK1 further phosphorylates and activates
  IKKβ, which in turn induces phosphorylation and degradation of IκBα, allowing NF-κB
  dimers to translocate to the nucleus and drive transcription of target genes. (B)
  Non-canonical NF-κB activation: The interaction of the receptor with the corresponding
  ligand recruits TRAFs and cIAP1/2 proteins to the receptors, resulting in their
  ceasing to mediate the ubiquitinated proteasomal degradation of NIK, leading to
  stabilization and accumulation of NIK and ultimately activation of the NF-κB pathway
  and transcription of target genes. (C) NODs-mediated NF-κB and MAPKs activation
  pathways. DAP, MDP binds to NOD1 and NOD2 receptors in the cytoplasm, respectively,
  which recruit RIPK2, cIAP1/2, and XIAP. rIPK2 undergoes IAP-mediated ubiquitination
  modifications and acts as a ubiquitin scaffold to recruit the TAK1 complex, the
  IKK complex and LUBAC. subsequently, TAK1 further activates the IKKβ/IκB/NF-κB signaling
  cascade. In addition, TAK1 also leads to the activation of MAPKs, which induce transcription
  of AP1 target genes. (D) Activation of TLRs triggers the MYD88-dependent signaling
  cascade that induces NF-κB and MAPK signaling activation. MYD88 recruits IRAKs,
  which then activates TRAF6. TRAF6 then recruits the TAK1 complex and the IKK complex.
  IKKβ is then phosphorylated by TAK1, which in turn phosphorylates IκB to activate
  NF-κB. TAK1 also activates the MAPK signaling cascade. The signaling cascade induced
  by TLRs also activates IRF3 and IRF5. Activated transcription factors translocate
  to the nucleus and induce the production of pro-inflammatory cytokines and type
  I IFN.'
papertitle: 'The Role of E3 Ubiquitin Ligases and Deubiquitinases in Inflammatory
  Bowel Disease: Friend or Foe?.'
reftext: Min Zou, et al. Front Immunol. 2021;12:769167.
year: '2021'
doi: 10.3389/fimmu.2021.769167
journal_title: Frontiers in Immunology
journal_nlm_ta: Front Immunol
publisher_name: Frontiers Media S.A.
keywords: inflammatory bowel disease | E3 ubiquitin ligases | deubiquitinases | ubiquitination
  | deubiquitination
automl_pathway: 0.918373
figid_alias: PMC8692584__F1
figtype: Figure
redirect_from: /figures/PMC8692584__F1
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC8692584__fimmu-12-769167-g001.html
  '@type': Dataset
  description: 'Activation and regulation of NF-κB pathway. (A) Canonical NF-κB activation:
    The binding of TNFRs to the ligands leads to the recruitment of TRADD, RIPK1.
    TRADD subsequently recruits E3 ubiquitin ligases, including TRAFs, cIAP1/2 and
    LUBAC. RIPK1 is then ubiquitinated and acts as a ubiquitin scaffold to recruit
    the IKK complex and the TAK1 complex. The IKK complex is comprised of IKKα, IKKβ,
    and NEMO. The TAK1 complex consists of TABs and TAK1.TAK1 further phosphorylates
    and activates IKKβ, which in turn induces phosphorylation and degradation of IκBα,
    allowing NF-κB dimers to translocate to the nucleus and drive transcription of
    target genes. (B) Non-canonical NF-κB activation: The interaction of the receptor
    with the corresponding ligand recruits TRAFs and cIAP1/2 proteins to the receptors,
    resulting in their ceasing to mediate the ubiquitinated proteasomal degradation
    of NIK, leading to stabilization and accumulation of NIK and ultimately activation
    of the NF-κB pathway and transcription of target genes. (C) NODs-mediated NF-κB
    and MAPKs activation pathways. DAP, MDP binds to NOD1 and NOD2 receptors in the
    cytoplasm, respectively, which recruit RIPK2, cIAP1/2, and XIAP. rIPK2 undergoes
    IAP-mediated ubiquitination modifications and acts as a ubiquitin scaffold to
    recruit the TAK1 complex, the IKK complex and LUBAC. subsequently, TAK1 further
    activates the IKKβ/IκB/NF-κB signaling cascade. In addition, TAK1 also leads to
    the activation of MAPKs, which induce transcription of AP1 target genes. (D) Activation
    of TLRs triggers the MYD88-dependent signaling cascade that induces NF-κB and
    MAPK signaling activation. MYD88 recruits IRAKs, which then activates TRAF6. TRAF6
    then recruits the TAK1 complex and the IKK complex. IKKβ is then phosphorylated
    by TAK1, which in turn phosphorylates IκB to activate NF-κB. TAK1 also activates
    the MAPK signaling cascade. The signaling cascade induced by TLRs also activates
    IRF3 and IRF5. Activated transcription factors translocate to the nucleus and
    induce the production of pro-inflammatory cytokines and type I IFN.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Cap1
  - Traf3
  - Prss8
  - Cap2
  - Serpinb8
  - Tmprss4
  - Sorbs1
  - Lnpep
  - Tnfaip3
  - Tab2
  - Tab3
  - Tab1
  - Trim28
  - Cdc37
  - Lsp1
  - Nfkb1
  - Pold2
  - Cd40
  - Dctn2
  - Tnf
  - Ripk1
  - Rela
  - Tnfrsf1a
  - Tnfrsf1b
  - Nfkbib
  - Phb2
  - Ikbkg
  - Chuk
  - Cyld
  - Trim31
  - Rnf183
  - Fbxw7
  - Usp9x
  - Ltbr
  - Tnfrsf13c
  - Gtf2h4
  - Nfkb2
  - Igbp1
  - Map4k4
  - Map3k14
  - Tpx2
  - Traf2
  - Gtf2h1
  - Nup62
  - Sqstm1
  - Khdrbs1
  - Dctn4
  - Cd40lg
  - lt
  - Ugt2b5
  - Tcf12
  - Relb
  - Xiap
  - Jun
  - Ripk2
  - Nod2
  - Nod1
  - Rel
  - Usp16
  - Usp21
  - Trim58
  - Tlr2
  - Myd88
  - Irf5
  - Tlr4
  - Nr2c2
  - Map3k7
  - Tbk1
  - Irf3
  - Ikbke
  - Trim21
  - CAP1
  - PRSS8
  - TRAF3
  - CAP2
  - SERPINB8
  - TMPRSS4
  - CTAA1
  - LNPEP
  - SERPINB6
  - HACD1
  - SORBS1
  - BRD4
  - TNFAIP3
  - IGKV1-27
  - TAB2
  - TAB3
  - TAB1
  - TRIM28
  - PSMA1
  - PSMA2
  - PSMA3
  - PSMA4
  - PSMA5
  - PSMA6
  - PSMA7
  - PSMA8
  - PSMB1
  - PSMB10
  - PSMB2
  - PSMB3
  - PSMB4
  - PSMB5
  - PSMB6
  - PSMB7
  - PSMB8
  - PSMB9
  - PSMC1
  - PSMC2
  - PSMC3
  - PSMC4
  - PSMC5
  - PSMC6
  - PSMD1
  - PSMD10
  - PSMD11
  - PSMD12
  - PSMD13
  - PSMD14
  - PSMD2
  - PSMD3
  - PSMD4
  - PSMD5
  - PSMD6
  - PSMD7
  - PSMD8
  - PSMD9
  - PSME1
  - PSME2
  - PSME3
  - PSMF1
  - SEM1
  - USP5
  - CD40
  - ARHGEF7
  - ASCC1
  - H3P40
  - TNF
  - RIPK1
  - RELA
  - TNFRSF1A
  - PHB2
  - IKBKG
  - CHUK
  - CYLD
  - TRIM31
  - RNF183
  - FBXW7
  - USP9X
  - LTBR
  - TNFRSF13C
  - FKBP4
  - GTF2H4
  - NFKB2
  - PMPCB
  - PSIP1
  - H3P42
  - MAP3K14
  - MAP4K4
  - CUX1
  - OAS3
  - PMEL
  - SART3
  - TPX2
  - SND1
  - ASCC2
  - TRAF2
  - TANK
  - GTF2H1
  - SQSTM1
  - KHDRBS1
  - NUP62
  - DCTN4
  - RNASE13
  - CD40LG
  - RELB
  - CXCL10
  - CXCL11
  - CXCL12
  - CXCL13
  - CXCL14
  - CXCL9
  - PF4
  - CXCL1
  - CXCL2
  - CXCL3
  - CXCL5
  - CXCL6
  - CXCL8
  - PPBP
  - XIAP
  - FOS
  - FOSB
  - JUN
  - JUNB
  - JUND
  - FOSL1
  - FOSL2
  - RIPK2
  - NOD2
  - NOD1
  - IKBKB
  - IKBKE
  - TBK1
  - REL
  - TRIM22
  - USP16
  - USP21
  - TRIM58
  - TLR2
  - MYD88
  - IRF5
  - TLR4
  - MAP3K7
  - NR2C2
  - IRF6
  - IRF3
  - TRIM21
  - cap1
  - cap2
  - tab2
  - tab3
  - tab1
  - nfkb1
  - tnfrsfa
  - tnfb
  - rela
  - ikbkg
  - cylda
  - rnf183
  - cd40
  - nfkb2
  - traf3
  - khdrbs1a
  - sqstm1
  - relb
  - xiap
  - ripk2
  - nod2
  - nod1
  - rel
  - usp16
  - tlr2
  - mid1ip1l
  - myd88
  - irf5
  - tbk1
  - irf3
  - btr01
---
